BBM-H803

BBM-H803注射液

Report date: 2026/03/27 20:01:50

Base Information

Drug NameBBM-H803
Drug Alias NameAdeno-associated Virus Vector Containing an Expression Cassette of the Human Factor VIII Transgene (Belief BioMed)AAV-Vector Containing an Expression Cassette of the Human Factor VIII Transgene (Belief BioMed)BBM-H803
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionFactor VIII gene transference
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBelef BioMed (Shanghai) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Mianyi Biotechnology Co LtdShanghai Belief-Delivery BioMed Co LtdBelef BioMed (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A